Avid Bioservices Inc (CDMO)

[JCNJ]

2 points on Opdivo v Bavi

1. Just yesterday, someone posted or I read that a big pharma just initiated a phase III trial in NSCLC using docetaxol as the MOS. To me that is a good sign, Doce is still the SOC

2. That we are even talking about Opdivo makes me even more sickened by the CSM situation. Bavi should have been approved/helping people and shareholders > 2 years ago!!

all imo good luck longs